InvestorsHub Logo
Followers 51
Posts 1681
Boards Moderated 0
Alias Born 02/15/2007

Re: None

Monday, 10/22/2012 9:45:06 PM

Monday, October 22, 2012 9:45:06 PM

Post# of 346282
Silver lining to the problem?
Let us assume that the phase IIb NSCLC trial data is corrected and released and still shows very good results.
We will know that the trial data will have been examined more thoroughly than most any other phase IIb trial, ever.
The FDA will have agreed to the release of the corrected data since they approved the initial trial and licensed CSM, Inc.
In this regard I think investors could put more faith in the results than before this happened.
It won't any longer be "too good to be true", but just "great".
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News